Psychoneuro-oncology: Its time has arrived

Archives of Dermatology

Volumn 145, Issue 12, 2009, Pages 1439-1442

  Smith, Nana ^a   Fuhrmann, Tracy ^b   Tausk, Francisco ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; GLUCOCORTICOID; NORADRENALIN;

ADRENERGIC SYSTEM; CELLULAR IMMUNITY; CYTOTOXICITY; DEPRESSION; EDITORIAL; MELANOMA; ONCOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SQUAMOUS CELL CARCINOMA; STRESS; VIRUS IMMUNITY;

DEPRESSIVE DISORDER; HUMANS; MELANOMA; SKIN NEOPLASMS; STRESS, PSYCHOLOGICAL;

EID: 73149111479     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.306     Document Type: Editorial

References (47)

1. Leshan L. Psychological states as factors in the development of malignant disease: a critical review. J Natl Cancer Inst. 1959;22(1):1-18.
2. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 2003;17(suppl 1):S27-S36.
3. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science. 1981;212(4499):1100-1109.
4. Azpiroz A, De Miguel Z, Fano E, Vegas O. Relations between different coping strategies for social stress, tumor development and neuroendocrine and immune activity in male mice. Brain Behav Immun. 2008;22(5):690-698.
5. Parker J, Klein SL, McClintockMK,et al. Chronic stress accelerates ultraviolet-induced cutaneous carcinogenesis. J Am Acad Dermatol. 2004;51(6):919-922.
6. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006; 6(3):240-248.
7. Tausk F, Elenkov I, Moynihan J. Psychoneuroimmunology. Dermatol Ther. 2008; 21(1):22-31.
8. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80(6):880-888.
9. Esterling BA, Kiecolt-Glaser JK, Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom Med. 1996;58 (3):264-272.
10. Tausk FA, Nousari H. Stress and the skin. Arch Dermatol. 2001;137(1):78-82.
11. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol. 1994;13(4):291-298.
12. Glaser R, Kiecolt-Glaser JK. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Ann Behav Med. 1997; 19(2):78-82.
13. Glaser R, Kiecolt-Glaser JK, Bonneau RH, Malarkey W, Kennedy S, Hughes J. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom Med. 1992;54(1):22-29.
14. Glaser R, Kiecolt-Glaser JK, Malarkey WB, Sheridan JF. The influence of psychological stress on the immune response to vaccines. Ann N Y Acad Sci. 1998; 840:649-655.
15. Glaser R, Pearson GR, Jones JF, et al. Stress-related activation of Epstein-Barr virus. Brain Behav Immun. 1991;5(2):219-232.
16. Glaser R, Thorn BE, Tarr KL, Kiecolt-Glaser JK, D'Ambrosio SM. Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol. 1985;4(5):403-412.
17. Kiecolt-Glaser JK, Stephens RE, Lipetz PD, Speicher CE, Glaser R. Distress and DNA repair in human lymphocytes. J Behav Med. 1985;8(4):311-320.
18. Dhillon VS, Dhillon IK. Chromosome aberrations and sister chromatid exchange studies in patients with prostate cancer: possible evidence of chromosome instability. Cancer Genet Cytogenet. 1998;100(2):143-147.
19. Fischman HK, Kelly DD. Sister chromatid exchanges induced by behavioral stress. Ann N Y Acad Sci. 1987;496:426-435.
20. Fischman HK, Kelly DD. Chromosomes and stress. Int J Neurosci. 1999;99(1-4): 201-219.
21. Fischman HK, Pero RW, Kelly DD. Psychogenic stress induces chromosomal and DNA damage. Int J Neurosci. 1996;84(1-4):219-227.
22. Tomei LD, Kanter P, Wenner CE. Inhibition of radiation-induced apoptosis in vitro by tumor promoters. Biochem Biophys Res Commun. 1988;155(1):324-331.
23. Tomei LD, Kiecolt-Glaser JK, Kennedy S, Glaser R. Psychological stress and phorbol ester inhibition of radiation-induced apoptosis in human peripheral blood leukocytes. Psychiatry Res. 1990;33(1):59-71.
24. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8): 939-944.
25. Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain Behav Immun. 2009;23(1):10-15.
26. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65(9):732-741.
27. Irwin MR. Depression and risk of cancer progression: an elusive link. J Clin Oncol. 2007;25(17):2343-2344.
28. Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007;25(17): 2397-2405.
29. Lutgendorf SK, Lamkin DM, Jennings NB, et al. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clin Cancer Res. 2008; 14(21):6839-6846.
30. Lutgendorf SK, DeGeest K, Sung CY, et al. Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav Immun. 2009;23(2):176-183.
31. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008;5(8): 466-475.
32. Kasparian NA, McLoone JK, Butow PN. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol. 2009;145(12):1415-1427.
33. Selye H. A syndrome produced by diverse nocuous agents: 1936. J Neuropsychiatry Clin Neurosci. 1998;10(2):230-231.
34. Selye H. The general adaptation syndrome and the disease of adaptation. J Clin Endocrinol. 1946;6:117-231.
35. McEwen BSWJ, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;43(1):2-15.
36. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338(3):171-179.
37. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med. 1985;20(8):833-840.
38. Temoshok L, Heller BW, Sagebiel RW, et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res. 1985;29(2):139-153.
39. Rogentine GN Jr, van Kammen DP, Fox BH, et al. Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom Med. 1979; 41(8):647-655.
40. Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P. Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res. 2007; 63(1):9-15.
41. Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol. 1999;17(7):2256-2263.
42. Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50(9):681-689.
43. Gibertini M, Reintgen DS, Baile WF. Psychosocial aspects of melanoma. Ann Plast Surg. 1992;28(1):17-21.
44. Rumpold G, Augustin M, Zschocke I, Strittmatter G, Sollner W. The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma [in German]. Psychother Psychosom Med Psychol. 2001;51(1):25-33.
45. Söllner W, Zingg-Schir M, Rumpold G, Mairinger G, Fritsch P. Need for supportive counselling: the professionals' versus the patients' perspective: a survey in a representative sample of 236 melanoma patients. Psychother Psychosom. 1998; 67(2):94-104.
46. Söllner W, Zingg-Schir M, Rumpold G, Fritsch P. Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol. 1997;133(3):316-321.
47. Gordon JS. Mind-body medicine and cancer. Hematol Oncol Clin North Am. 2008; 22(4):683-708, ix.